S&P 500 7,757.17 +0.58%
Nasdaq 26,702.86 +1.05%
S&P/TSX 36,324.99 +0.60%
Apple 343.99 +0.31%
Nvidia 221.97 +2.25%
Microsoft 532.95 −0.11%
Shopify 244.93 +0.38%
Royal Bank 283.62 +1.23%
CAD/USD 0.7120 +0.15%
CLOSED · 20:15 ET
Market ClerkRecap
Wed Oct 21 · markets closed2 signals today78 insider buys this week · $240.8MCIRO short report next: Oct 31The week ahead

RPRX

Royalty Pharma plc
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
62.15
−0.10 −0.16%
USD · close Oct 21

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $24.1BP/E 33.1DIV YIELD 1.46%FCF YIELD —REV TTM $2.5B +10.0%NET INCOME $815M −20.4%NET DEBT $8.1B52W 36.41 – 63.96SEC XBRL · TTM TO Invalid Date

What RPRX had to tell the SEC

FORM 8-K · TWO YEARS · MOST RECENT FIRST
No 8-K filings from RPRX on record yet. The events worker reads new filings each morning; older ones appear as the sweep reaches them.

Items read from each filing’s EDGAR index page; labels are ours. Every tracked company’s 8-Ks, most serious first.

Watch RPRX. Know when insiders buy.
One email the day a filing lands. Free.